vs
Side-by-side financial comparison of Organon & Co. (OGN) and UGI CORP (UGI). Click either name above to swap in a different company.
UGI CORP is the larger business by last-quarter revenue ($2.1B vs $1.5B, roughly 1.4× Organon & Co.). UGI CORP runs the higher net margin — 14.4% vs -13.6%, a 28.0% gap on every dollar of revenue. On growth, UGI CORP posted the faster year-over-year revenue change (3.9% vs -5.3%). Organon & Co. produced more free cash flow last quarter ($96.0M vs $-155.0M). Over the past eight quarters, Organon & Co.'s revenue compounded faster (-3.6% CAGR vs -7.5%).
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy (HRT), and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States.
UGI Corporation is a natural gas and electric power distribution company headquartered in King of Prussia, Pennsylvania, with extensive operations in the United States and Europe.
OGN vs UGI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.5B | $2.1B |
| Net Profit | $-205.0M | $297.0M |
| Gross Margin | 49.2% | — |
| Operating Margin | -9.8% | 22.0% |
| Net Margin | -13.6% | 14.4% |
| Revenue YoY | -5.3% | 3.9% |
| Net Profit YoY | -288.1% | -20.8% |
| EPS (diluted) | $-0.78 | $1.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.5B | $2.1B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.6B | $1.4B | ||
| Q1 25 | $1.5B | $2.6B | ||
| Q4 24 | $1.6B | $2.0B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.6B | $1.4B | ||
| Q1 24 | $1.6B | $2.4B |
| Q4 25 | $-205.0M | $297.0M | ||
| Q3 25 | $160.0M | $-13.0M | ||
| Q2 25 | $145.0M | $-163.0M | ||
| Q1 25 | $87.0M | $479.0M | ||
| Q4 24 | $109.0M | $375.0M | ||
| Q3 24 | $359.0M | $-273.0M | ||
| Q2 24 | $195.0M | $-48.0M | ||
| Q1 24 | $201.0M | $496.0M |
| Q4 25 | 49.2% | — | ||
| Q3 25 | 53.5% | — | ||
| Q2 25 | 54.8% | — | ||
| Q1 25 | 55.6% | — | ||
| Q4 24 | 56.3% | — | ||
| Q3 24 | 58.3% | — | ||
| Q2 24 | 58.4% | — | ||
| Q1 24 | 59.0% | — |
| Q4 25 | -9.8% | 22.0% | ||
| Q3 25 | 15.2% | 1.1% | ||
| Q2 25 | 14.4% | -6.8% | ||
| Q1 25 | 6.7% | 26.6% | ||
| Q4 24 | 8.1% | 24.5% | ||
| Q3 24 | 13.1% | -20.4% | ||
| Q2 24 | 14.6% | 5.0% | ||
| Q1 24 | 14.5% | 29.7% |
| Q4 25 | -13.6% | 14.4% | ||
| Q3 25 | 10.0% | -1.1% | ||
| Q2 25 | 9.1% | -12.0% | ||
| Q1 25 | 5.8% | 18.2% | ||
| Q4 24 | 6.8% | 18.9% | ||
| Q3 24 | 22.7% | -22.6% | ||
| Q2 24 | 12.1% | -3.6% | ||
| Q1 24 | 12.4% | 20.6% |
| Q4 25 | $-0.78 | $1.34 | ||
| Q3 25 | $0.61 | $-0.08 | ||
| Q2 25 | $0.56 | $-0.76 | ||
| Q1 25 | $0.33 | $2.19 | ||
| Q4 24 | $0.42 | $1.74 | ||
| Q3 24 | $1.38 | $-1.26 | ||
| Q2 24 | $0.75 | $-0.23 | ||
| Q1 24 | $0.78 | $2.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $574.0M | $251.0M |
| Total DebtLower is stronger | $8.6B | $6.0B |
| Stockholders' EquityBook value | $752.0M | $5.0B |
| Total Assets | $12.9B | $15.8B |
| Debt / EquityLower = less leverage | 11.49× | 1.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $574.0M | $251.0M | ||
| Q3 25 | $672.0M | $335.0M | ||
| Q2 25 | $599.0M | $350.0M | ||
| Q1 25 | $547.0M | $426.0M | ||
| Q4 24 | $675.0M | $240.0M | ||
| Q3 24 | $763.0M | $213.0M | ||
| Q2 24 | $704.0M | $183.0M | ||
| Q1 24 | $575.0M | $263.0M |
| Q4 25 | $8.6B | $6.0B | ||
| Q3 25 | $8.8B | $6.5B | ||
| Q2 25 | $8.9B | $5.7B | ||
| Q1 25 | $9.0B | $6.6B | ||
| Q4 24 | $8.9B | $6.6B | ||
| Q3 24 | $8.7B | $6.4B | ||
| Q2 24 | $8.7B | $6.3B | ||
| Q1 24 | $8.7B | $6.7B |
| Q4 25 | $752.0M | $5.0B | ||
| Q3 25 | $906.0M | $4.8B | ||
| Q2 25 | $733.0M | $4.9B | ||
| Q1 25 | $542.0M | $5.0B | ||
| Q4 24 | $472.0M | $4.6B | ||
| Q3 24 | $493.0M | $4.3B | ||
| Q2 24 | $144.0M | $4.7B | ||
| Q1 24 | $48.0M | $4.8B |
| Q4 25 | $12.9B | $15.8B | ||
| Q3 25 | $13.6B | $15.5B | ||
| Q2 25 | $13.5B | $15.4B | ||
| Q1 25 | $13.2B | $15.7B | ||
| Q4 24 | $13.1B | $15.4B | ||
| Q3 24 | $12.8B | $15.1B | ||
| Q2 24 | $12.2B | $15.1B | ||
| Q1 24 | $11.9B | $15.6B |
| Q4 25 | 11.49× | 1.19× | ||
| Q3 25 | 9.74× | 1.37× | ||
| Q2 25 | 12.14× | 1.17× | ||
| Q1 25 | 16.52× | 1.32× | ||
| Q4 24 | 18.81× | 1.44× | ||
| Q3 24 | 17.75× | 1.48× | ||
| Q2 24 | 60.11× | 1.34× | ||
| Q1 24 | 181.54× | 1.40× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $141.0M | $66.0M |
| Free Cash FlowOCF − Capex | $96.0M | $-155.0M |
| FCF MarginFCF / Revenue | 6.4% | -7.5% |
| Capex IntensityCapex / Revenue | 3.0% | 10.7% |
| Cash ConversionOCF / Net Profit | — | 0.22× |
| TTM Free Cash FlowTrailing 4 quarters | $538.0M | $282.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $141.0M | $66.0M | ||
| Q3 25 | $264.0M | $90.0M | ||
| Q2 25 | $220.0M | $289.0M | ||
| Q1 25 | $75.0M | $684.0M | ||
| Q4 24 | $390.0M | $164.0M | ||
| Q3 24 | $141.0M | $151.0M | ||
| Q2 24 | $332.0M | $390.0M | ||
| Q1 24 | $76.0M | $522.0M |
| Q4 25 | $96.0M | $-155.0M | ||
| Q3 25 | $218.0M | $-168.0M | ||
| Q2 25 | $181.0M | $67.0M | ||
| Q1 25 | $43.0M | $538.0M | ||
| Q4 24 | $335.0M | $-47.0M | ||
| Q3 24 | $99.0M | $-115.0M | ||
| Q2 24 | $300.0M | $185.0M | ||
| Q1 24 | $30.0M | $353.0M |
| Q4 25 | 6.4% | -7.5% | ||
| Q3 25 | 13.6% | -14.4% | ||
| Q2 25 | 11.4% | 4.9% | ||
| Q1 25 | 2.8% | 20.4% | ||
| Q4 24 | 21.0% | -2.4% | ||
| Q3 24 | 6.3% | -9.5% | ||
| Q2 24 | 18.7% | 13.7% | ||
| Q1 24 | 1.8% | 14.6% |
| Q4 25 | 3.0% | 10.7% | ||
| Q3 25 | 2.9% | 22.1% | ||
| Q2 25 | 2.4% | 16.3% | ||
| Q1 25 | 2.1% | 5.5% | ||
| Q4 24 | 3.5% | 10.6% | ||
| Q3 24 | 2.7% | 22.0% | ||
| Q2 24 | 2.0% | 15.2% | ||
| Q1 24 | 2.8% | 7.0% |
| Q4 25 | — | 0.22× | ||
| Q3 25 | 1.65× | — | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 0.86× | 1.43× | ||
| Q4 24 | 3.58× | 0.44× | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 1.70× | — | ||
| Q1 24 | 0.38× | 1.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
